A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH | MicrobiomeTrials← Back to trialsNCT07221227
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2025-10-24Est. Completion: 2028-03-29
Enrollment target: 1,200 participants Locations- GSK Investigational Site, Chandler, Arizona, United States
- GSK Investigational Site, Tucson, Arizona, United States
- GSK Investigational Site, Little Rock, Arkansas, United States
- GSK Investigational Site, Arcadia, California, United States
- GSK Investigational Site, Covina, California, United States
- GSK Investigational Site, Folsom, California, United States
- GSK Investigational Site, Los Angeles, California, United States
- GSK Investigational Site, Montclair, California, United States
- GSK Investigational Site, Riverdale, California, United States
- GSK Investigational Site, San Diego, California, United States
- GSK Investigational Site, Santa Maria, California, United States
- GSK Investigational Site, Van Nuys, California, United States
- GSK Investigational Site, Colorado Springs, Colorado, United States
- GSK Investigational Site, Boynton Beach, Florida, United States
- GSK Investigational Site, Cape Coral, Florida, United States
- GSK Investigational Site, Clermont, Florida, United States
Other microbiome trials you might be interested in
Non-Alcoholic Fatty Liver DiseaseObesity
This will be a 6-month randomized clinical trial with two arms: moderately carbohydrate-restricted diet and a fat-restri…
Birmingham, United StatesCompleted Jul 21, 2026
Non-alcoholic Fatty Liver Disease
This study will evaluate the safety and tolerability of Efimosfermin Alfa for participants with known or suspected MASH …
Arcadia, United StatesEst. completion Mar 24, 2028
GSK Investigational Site, Fort Myers, Florida, United StatesGSK Investigational Site, Hialeah, Florida, United StatesGSK Investigational Site, Hialeah, Florida, United StatesGSK Investigational Site, Homestead, Florida, United StatesGSK Investigational Site, Inverness, Florida, United StatesGSK Investigational Site, Jacksonville, Florida, United StatesGSK Investigational Site, Kissimmee, Florida, United StatesGSK Investigational Site, Lakeland, Florida, United StatesGSK Investigational Site, Maitland, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami, Florida, United StatesGSK Investigational Site, Miami Lakes, Florida, United StatesGSK Investigational Site, Ocala, Florida, United StatesGSK Investigational Site, Palmetto Bay, Florida, United StatesGSK Investigational Site, Sarasota, Florida, United StatesGSK Investigational Site, Marietta, Georgia, United StatesGSK Investigational Site, Topeka, Kansas, United StatesGSK Investigational Site, Bastrop, Louisiana, United StatesGSK Investigational Site, Marrero, Louisiana, United StatesGSK Investigational Site, Kansas City, Missouri, United StatesGSK Investigational Site, Springfield, Missouri, United StatesGSK Investigational Site, St Louis, Missouri, United StatesGSK Investigational Site, Las Vegas, Nevada, United StatesGSK Investigational Site, East Syracuse, New York, United StatesGSK Investigational Site, New York, New York, United StatesGSK Investigational Site, New York, New York, United StatesGSK Investigational Site, Fayetteville, North Carolina, United StatesGSK Investigational Site, Morehead City, North Carolina, United StatesGSK Investigational Site, Akron, Ohio, United StatesGSK Investigational Site, Springboro, Ohio, United StatesGSK Investigational Site, Westlake, Ohio, United StatesGSK Investigational Site, Chattanooga, Tennessee, United StatesGSK Investigational Site, Arlington, Texas, United StatesGSK Investigational Site, Austin, Texas, United StatesGSK Investigational Site, Austin, Texas, United StatesGSK Investigational Site, Austin, Texas, United StatesGSK Investigational Site, Bellaire, Texas, United StatesGSK Investigational Site, Brownsville, Texas, United StatesGSK Investigational Site, Dallas, Texas, United StatesGSK Investigational Site, DeSoto, Texas, United StatesGSK Investigational Site, Houston, Texas, United StatesGSK Investigational Site, Irving, Texas, United StatesGSK Investigational Site, Richmond, Texas, United StatesGSK Investigational Site, San Antonio, Texas, United StatesGSK Investigational Site, San Antonio, Texas, United StatesGSK Investigational Site, San Antonio, Texas, United StatesGSK Investigational Site, Seabrook, Texas, United StatesGSK Investigational Site, Sugar Land, Texas, United StatesGSK Investigational Site, Tomball, Texas, United StatesGSK Investigational Site, Waco, Texas, United StatesGSK Investigational Site, Waco, Texas, United StatesGSK Investigational Site, West Jordan, Utah, United StatesGSK Investigational Site, Manassas, Virginia, United StatesGSK Investigational Site, Norfolk, Virginia, United StatesGSK Investigational Site, Seattle, Washington, United StatesGSK Investigational Site, Broadmeadow, New South Wales, AustraliaGSK Investigational Site, Heidelberg, Victoria, AustraliaGSK Investigational Site, Québec, Quebec, CanadaGSK Investigational Site, Pokfulam, Hong KongGSK Investigational Site, Gifu, JapanGSK Investigational Site, Kanagawa, JapanGSK Investigational Site, Kyoto, JapanGSK Investigational Site, Musashino, JapanGSK Investigational Site, Yokohama, JapanGSK Investigational Site, Wellington, New ZealandGSK Investigational Site, San Juan, Puerto RicoGSK Investigational Site, Riyadh, Saudi ArabiaGSK Investigational Site, Chiayi City, TaiwanGSK Investigational Site, Kaohsiung City, TaiwanGSK Investigational Site, Kaohsiung City, Taiwan